Efficacy and Safety of Telitacicept in IgAN

NCT06654596 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

118

Enrollment

OTHER

Sponsor class

Conditions

IgA Nephropathy (IgAN)
Kidney Diseases
Telitacicept
Glucocorticoid

Interventions

DRUG: Telitacicept 240mg
DRUG: Glucocorticoid

Sponsor

Ruijin Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]